Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Holst

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Cell|June 28, 1996
GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNFS Jing, D Wen, Y Yu, et al.
Journal of Autism and Developmental Disorders|November 6, 2025
Factors Associated With the Use of Complementary and Alternative Medicine by Autistic PreschoolersSteven A Rosenberg, Brady L Holst, Sarah J Schmiege, et al.
BMC Pediatrics|March 21, 2007
Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South AfricaAnand Reddi, Sarah C Leeper, Anneke C Grobler, et al.
ACS Medicinal Chemistry Letters|August 20, 2015
Discovery of BMS-641988, a Novel Androgen Receptor Antagonist for the Treatment of Prostate CancerAaron Balog, Richard Rampulla, Gregory S Martin, et al.
Bioorganic & Medicinal Chemistry Letters|June 30, 2010
Design and synthesis of 4-[3,5-dioxo-11-oxa-4,9-diazatricyclo[5.3.1.0(2,6)]undec-4-yl]-2-trifluoromethyl-benzonitriles as androgen receptor antagonistsHai-Yun Xiao, Aaron Balog, Ricardo M Attar, et al.
Journal of Medicinal Chemistry|October 14, 2009
Discovery and preclinical evaluation of [4-[[1-(3-fluorophenyl)methyl]-1H-indazol-5-ylamino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamic acid, (3S)-3-morpholinylmethyl ester (BMS-599626), a selective and orally efficacious inhibitor of human epidermal growth factor receptor 1 and 2 kinasesAshvinikumar V Gavai, Brian E Fink, David J Fairfax, et al.
Bioorganic & Medicinal Chemistry Letters|June 11, 2016
Discovery of potent macrocyclic HCV NS5A inhibitorsWensheng Yu, Bancha Vibulbhan, Stuart B Rosenblum, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2016
Discovery of silyl proline containing HCV NS5A inhibitors with pan-genotype activity: SAR developmentAnilkumar G Nair, Qingbei Zeng, Oleg Selyutin, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Cell|June 28, 1996
GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNFS Jing, D Wen, Y Yu, et al.
Journal of Autism and Developmental Disorders|November 6, 2025
Factors Associated With the Use of Complementary and Alternative Medicine by Autistic PreschoolersSteven A Rosenberg, Brady L Holst, Sarah J Schmiege, et al.
BMC Pediatrics|March 21, 2007
Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South AfricaAnand Reddi, Sarah C Leeper, Anneke C Grobler, et al.
ACS Medicinal Chemistry Letters|August 20, 2015
Discovery of BMS-641988, a Novel Androgen Receptor Antagonist for the Treatment of Prostate CancerAaron Balog, Richard Rampulla, Gregory S Martin, et al.
Bioorganic & Medicinal Chemistry Letters|June 30, 2010
Design and synthesis of 4-[3,5-dioxo-11-oxa-4,9-diazatricyclo[5.3.1.0(2,6)]undec-4-yl]-2-trifluoromethyl-benzonitriles as androgen receptor antagonistsHai-Yun Xiao, Aaron Balog, Ricardo M Attar, et al.
Journal of Medicinal Chemistry|October 14, 2009
Discovery and preclinical evaluation of [4-[[1-(3-fluorophenyl)methyl]-1H-indazol-5-ylamino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamic acid, (3S)-3-morpholinylmethyl ester (BMS-599626), a selective and orally efficacious inhibitor of human epidermal growth factor receptor 1 and 2 kinasesAshvinikumar V Gavai, Brian E Fink, David J Fairfax, et al.
Bioorganic & Medicinal Chemistry Letters|June 11, 2016
Discovery of potent macrocyclic HCV NS5A inhibitorsWensheng Yu, Bancha Vibulbhan, Stuart B Rosenblum, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2016
Discovery of silyl proline containing HCV NS5A inhibitors with pan-genotype activity: SAR developmentAnilkumar G Nair, Qingbei Zeng, Oleg Selyutin, et al.
Pageof 4